Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors-Reference-Cited by-同舟云学术

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors

Published:2022-03-01 Issue:3 Volume:8 Page:404
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Guru Murthy Guru Subramanian¹,Kim Soyoung²³,Hu Zhen-Huan²,Estrada-Merly Noel²,Abid Muhammad Bilal¹⁴,Aljurf Mahmoud⁵,Bacher Ulrike⁶,Badawy Sherif M.⁷⁸,Beitinjaneh Amer⁹,Bredeson Chris¹⁰,Cahn Jean-Yves¹¹,Cerny Jan¹²,Diaz Perez Miguel Angel¹³,Farhadfar Nosha¹⁴,Gale Robert Peter¹⁵,Ganguly Siddhartha¹⁶,Gergis Usama¹⁷,Hildebrandt Gerhard C.¹⁸,Grunwald Michael R.¹⁹,Hashmi Shahrukh²⁰²¹,Hossain Nasheed M.²²,Kalaycio Matt²³,Kamble Rammurti T.²⁴,Kharfan-Dabaja Mohamed A.²⁵,Hamilton Betty Ky²³,Lazarus Hillard M.²⁶,Liesveld Jane²⁷,Litzow Mark²⁸,Marks David I.²⁹,Murthy Hemant S.²⁵,Nathan Sunita³⁰,Nazha Aziz³¹,Nishihori Taiga³²,Patel Sagar S.³³,Pawarode Attaphol³⁴,Rizzieri David³⁵,Savani Bipin³⁶,Seo Sachiko³⁷,Solh Melhem³⁸,Ustun Celalettin³⁹,van der Poel Marjolein⁴⁰,Verdonck Leo F.⁴¹,Vij Ravi⁴²,Wirk Baldeep⁴³,Oran Betul⁴⁴,Nakamura Ryotaro⁴⁵,Scott Bart⁴⁶,Saber Wael²

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee

2. Department of Medicine, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee

3. Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee

4. Division of Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee

5. Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh, Saudi Arabia

6. Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

7. Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois

8. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois

9. Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida

10. Ottawa Hospital Transplant and Cellular Therapy Program, The Ottawa Hospital, Ottawa, Ontario, Canada

11. Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble, France

12. Division of Hematology-Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester

13. Department of Hematology and Oncology, Hospital Infantil Universitario Niño Jesus, Madrid, Spain

14. Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville

15. Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK

16. Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City

17. Division of Hematological Malignancies, Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania

18. Markey Cancer Center, University of Kentucky College of Medicine, Lexington

19. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina

20. Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota

21. Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates

22. Division of Hematology and Oncology, Stem Cell Transplant Program, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois

23. Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio

24. Divsion of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas

25. Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida

26. Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio

27. Department of Medicine, University of Rochester Medical Center, Rochester, New York

28. Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, Minnesota

29. Adult Bone Marrow Transplant, University Hospitals Bristol National Health Service Trust, Bristol, UK

30. Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois

31. Cleveland Clinic Foundation, Cleveland, Ohio

32. Department of Blood and Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center, Tampa, Florida

33. Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City

34. Blood and Marrow Transplantation Program, Division of Hematology and Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor

35. Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina

36. Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

37. Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan

38. Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta

39. Division of Hematology, Oncology, and Cell Therapy, Rush University, Chicago, Illinois

40. Maastricht University Medical Center, Maastricht, the Netherlands

41. Department of Hematology and Oncology, Isala Clinic, Zwolle, the Netherlands

42. Division of Hematology and Oncology, Washington University School of Medicine, St Louis, Missouri

43. Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania

44. Division of Cancer Medicine, Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston

45. Department of Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California

46. Fred Hutchinson Cancer Research Center, Seattle, Washington

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2788054/jamaoncology_guru_murthy_2022_oi_210098_1647458341.90209.pdf

Reference31 articles.

1. Current use of and trends in hematopoietic cell transplantation in the United States.;D’Souza;Biol Blood Marrow Transplant,2020

2. Epidemiology of myelodysplastic syndromes.;Ma;Am J Med,2012

3. Outcome after relapse of myelodysplastic syndrome and secondary acute myeloid leukemia following allogeneic stem cell transplantation: a retrospective registry analysis on 698 patients by the Chronic Malignancies Working Party of the European Society of Blood and Marrow Transplantation.;Schmid;Haematologica,2018

4. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.;Lee;Blood,2007

5. Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy.;Nakasone;Haematologica,2015

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;Bone Marrow Transplantation;2024-08-18

2. Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study;Blood Advances;2024-08-14

3. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT;Blood Advances;2024-07-26

4. Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide;Leukemia;2024-07-24

5. Unrelated hematopoietic stem cell donor registries: present reality and future prospects;Current Opinion in Hematology;2024-07-22